The "C19orf12 Gene Neurodegeneration with Brain Iron Accumulation Type 4 Genetic Test" is a specialized diagnostic examination conducted to identify mutations in the C19orf12 gene, which are associated with Neurodegeneration with Brain Iron Accumulation Type 4 (NBIA-4), also known as Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN). This condition is characterized by progressive neurodegeneration and the accumulation of iron in specific areas of the brain, leading to a range of neurological symptoms such as movement disorders, psychiatric symptoms, and cognitive decline.
The test is designed to provide crucial genetic information for the accurate diagnosis and management of individuals suspected to have or at risk of developing NBIA-4. By analyzing the C19orf12 gene, healthcare providers can confirm the diagnosis, understand the disease's progression, and potentially tailor treatment strategies to manage symptoms more effectively.
This genetic test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the test is 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by professionals with expertise in genetic diagnostics, ensuring high-quality testing and reliable results for patients and their families.
The COASY Gene Neurodegeneration with Brain Iron Accumulation Type 6 (NBIA6) genetic test is a specialized diagnostic tool used to identify mutations in the COASY gene, which are linked to a rare form of neurodegeneration characterized by the accumulation of iron in the brain. This condition, known as NBIA6, can lead to a range of neurological symptoms, including movement disorders, psychiatric issues, and progressive deterioration of motor functions. The test is crucial for confirming a diagnosis, enabling early intervention, and facilitating appropriate management and treatment strategies for affected individuals.
Conducted at DNA Labs UAE, the test involves a detailed analysis of the patient's DNA to detect any abnormalities or mutations in the COASY gene that could indicate the presence of NBIA6. This state-of-the-art genetic testing provides families and healthcare professionals with essential information regarding the genetic basis of the condition, helping to guide treatment decisions and offering insights into potential genetic counseling needs for the family.
The cost of the COASY Gene Neurodegeneration with Brain Iron Accumulation Type 6 Genetic Test at DNA Labs UAE is 4400 AED. Given the specialized nature of the test and the expertise required to accurately interpret the results, this cost reflects the comprehensive analysis and personalized care that patients receive. For families facing the challenges of NBIA6, this test represents a critical step towards understanding and managing the condition more effectively.
The COL6A2 gene plays a crucial role in the body's connective tissue, contributing to the integrity and strength of skin, muscles, and other tissues. Mutations in the COL6A2 gene can lead to a condition known as myosclerosis, a form of muscular dystrophy characterized by muscle stiffness and fibrosis, often leading to decreased mobility and flexibility.
The COL6A2 Gene Myosclerosis Autosomal Recessive Genetic Test is a specialized diagnostic tool designed to identify mutations in the COL6A2 gene, helping to confirm a diagnosis of myosclerosis. This test is particularly important for individuals with a family history of the condition or those exhibiting symptoms, as it can provide crucial information for managing the disease.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive analysis of the COL6A2 gene. The cost of the test is 4400 AED, reflecting the intricate technology and expertise required to accurately detect mutations associated with myosclerosis. By opting for this test, patients and their families can gain valuable insights into their genetic makeup, paving the way for targeted treatments and informed decisions about their health care.
The MYH7 gene myosin storage myopathy genetic test is a specialized diagnostic procedure aimed at detecting mutations in the MYH7 gene, which is known to cause myosin storage myopathy (MSM). This condition is a rare genetic disorder affecting skeletal muscles, leading to muscle weakness and other symptoms. The test involves analyzing the patient's DNA to identify any genetic alterations in the MYH7 gene that are indicative of the disease. Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, this test provides crucial information for the diagnosis, management, and understanding of myosin storage myopathy. The cost of the test is set at 4400 AED, reflecting the intricate processes and sophisticated technology employed in identifying the genetic mutations associated with this condition.
The MYOT gene myotilinopathy genetic test is a specialized diagnostic tool designed to identify mutations in the MYOT gene, which are linked to the development of myotilinopathy, a rare form of muscular dystrophy. This condition is characterized by muscle weakness and atrophy, primarily affecting the skeletal muscles. Early diagnosis through this genetic test can be crucial for managing symptoms, implementing appropriate treatment plans, and understanding the inheritance pattern within affected families.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the patient's DNA to detect specific genetic alterations in the MYOT gene that are responsible for the condition. The process is comprehensive, ensuring high accuracy and reliability in the results.
The cost of the MYOT gene myotilinopathy genetic test at DNA Labs UAE is set at 4400 AED. While the price might seem significant, the value of obtaining a precise diagnosis cannot be understated, as it opens the door to targeted therapies and interventions, potentially improving the quality of life for individuals with myotilinopathy.
The CLCN1 Gene Myotonia Congenita Genetic Test is a specialized diagnostic tool designed to identify mutations in the CLCN1 gene, which are responsible for causing Myotonia Congenita. This condition is a genetic disorder characterized by muscle stiffness and delayed relaxation of muscles after contraction. The test involves analyzing the patient's DNA to detect any genetic anomalies in the CLCN1 gene that might lead to the development of Myotonia Congenita.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive evaluation to help in the diagnosis and management of this condition. The cost of the test is 4400 AED, reflecting the intricate technology and expertise required to accurately identify mutations in the CLCN1 gene. This test is crucial for individuals experiencing symptoms of Myotonia Congenita or those with a family history of the condition, as it can provide valuable insights into treatment options and genetic counseling.
The DMPK Gene Myotonic Dystrophy Type 1 Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the DMPK gene, which are responsible for causing Myotonic Dystrophy Type 1 (DM1). This condition is characterized by progressive muscle loss and weakness, myotonia, and various other systemic issues. The test involves analyzing the patient's DNA to identify the specific genetic alteration within the DMPK gene, known as a CTG triplet repeat expansion. The presence and size of the expansion can help in confirming the diagnosis of DM1 and predicting the severity of the condition.
Offered by DNA Labs UAE, this genetic test is a critical tool for individuals suspected of having Myotonic Dystrophy Type 1 or for those with a family history of the disease, aiming to provide a clear genetic diagnosis. The test is priced at 4400 AED and is conducted in a state-of-the-art laboratory setting, ensuring high accuracy and reliability of the results. Through this test, patients and their families can gain valuable insights into the genetic basis of the condition, which can significantly aid in managing the disease and planning for the future.
The CNBP Gene Myotonic Dystrophy Type 2 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the CNBP gene, which are responsible for causing Myotonic Dystrophy Type 2 (DM2). DM2 is a form of muscular dystrophy that affects muscle function and can lead to a range of symptoms from myotonia, muscle weakness, cataracts, to heart problems. This genetic test is crucial for individuals with a family history of DM2 or those exhibiting symptoms, as it provides definitive diagnosis, allowing for appropriate management and treatment plans to be established. The test is priced at 4400 AED and involves a detailed analysis of the patient's DNA to detect the specific genetic mutation associated with the condition. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test represents a significant step forward in the personalized care and management of patients with Myotonic Dystrophy Type 2.
The MTM1 Gene Myotubular Myopathy X-Linked Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the MTM1 gene, which are responsible for causing X-linked myotubular myopathy (XLMTM). This rare, inherited disorder primarily affects skeletal muscles, leading to muscle weakness, respiratory difficulties, and in severe cases, early mortality. The condition predominantly affects males due to its X-linked inheritance pattern.
Given the critical nature of early diagnosis for managing symptoms and planning treatment strategies, this genetic test plays a vital role in identifying affected individuals. The test involves analyzing the patient's DNA to detect any abnormalities in the MTM1 gene, which provides instructions for producing myotubularin, a protein essential for muscle cell function.
The cost of the MTM1 Gene Myotubular Myopathy X-Linked Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the testing, including the sophisticated techniques used to accurately identify gene mutations and the professional expertise required to interpret the results. Undergoing this test at DNA Labs UAE ensures access to cutting-edge genetic testing technology, along with support from experienced genetic counselors who can provide valuable insights into the implications of the test results for the patient and their family.
The HCRT Gene Narcolepsy Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the hypocretin (orexin) receptor 2 gene (HCRT), which are strongly associated with the development of narcolepsy. Narcolepsy is a chronic sleep disorder characterized by overwhelming daytime drowsiness and sudden attacks of sleep, often leading to significant disruptions in daily life. This genetic test plays a crucial role in the early detection and diagnosis of narcolepsy, allowing for timely intervention and management of the condition.
Performed in the state-of-the-art facilities of DNA Labs UAE, the test requires a simple blood sample from the patient. The sample is then analyzed for specific genetic markers that indicate a predisposition to narcolepsy. The process is highly accurate, leveraging advanced genetic sequencing techniques to ensure reliable results.
The cost of the HCRT Gene Narcolepsy Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of early detection and the potential for improved quality of life through personalized treatment plans make it a worthwhile investment for individuals experiencing symptoms of narcolepsy or those with a family history of the disorder.
